Market closed

Clearwater Analytics/$CWAN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Clearwater Analytics

Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.

Ticker

$CWAN
Sector
Information Technology

Trading on

NYSE

Industry

Software
Headquarters
Boise, United States

Employees

1,756
Website
clearwateranalytics.com

CWAN Metrics

BasicAdvanced
$5.9B
8676.72
$0.00
0.60
-

$5.9B

0.6

$32.25

$15.62

2.6M

4.663

4.48

13.878

16.205

3.25%

0.91%

8,676.717

13.057

14.1

19.27

45.558

20.61%

-102.90%

21.43%

-81.26%

What the Analysts think about CWAN

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Clearwater Analytics stock.

CWAN Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CWAN Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

CWAN News

AllArticlesVideos
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN

ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN

Business Wire·1 day ago
Clearwater Analytics to acquire Enfusion in $1.5 bln deal

Clearwater Analytics to acquire Enfusion in $1.5 bln deal

Reuters·2 days ago
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

Business Wire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CWAN

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Clearwater Analytics stock?

Clearwater Analytics (CWAN) has a market cap of $5.9B as of January 15, 2025.

What is the P/E ratio for Clearwater Analytics stock?

The price to earnings (P/E) ratio for Clearwater Analytics (CWAN) stock is 8676.72 as of January 15, 2025.

Does Clearwater Analytics stock pay dividends?

No, Clearwater Analytics (CWAN) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Clearwater Analytics dividend payment date?

Clearwater Analytics (CWAN) stock does not pay dividends to its shareholders.

What is the beta indicator for Clearwater Analytics?

Clearwater Analytics (CWAN) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.